Use of abciximab prior to primary angioplasty in STEMI results in early recanalization of the infarct-related artery and improved myocardial tissue reperfusion - Results of the Austrian multi-centre randomized ReoPro-BRIDGING Study

European Heart Journal

Volumn 25, Issue 23, 2004, Pages 2125-2133

  Gyöngyösi, Mariann ^a   Domanovits, Hans ^a   Benzer, Werner ^b   Haugk, Moritz ^a   Heinisch, Birgit ^a   Sodeck, Gottfried ^a   Hödl, Ronald ^c   Gaul, Georg ^d   Bonner, Gerhard ^e   Wojta, Johann ^a   Laggner, Anton ^a   Glogar, Dietmar ^a   Huber, Kurt ^f  

^a UNIVERSITY OF VIENNA   (Austria)

^b Academic Hospital   (Austria)

^c UNIVERSITY OF GRAZ   (Austria)

^d HANUSCH HOSPITAL   (Austria)

^e Rudolfstiftung   (Austria)

^f 3rd Department of Medicine   (Austria)

Author keywords

GP IIb IIIa antagonist; Infarct related artery; Primary percutaneous coronary angioplasty; ST elevation myocardial infarction

Indexed keywords

ABCIXIMAB; HEART ENZYME;

ADULT; AGED; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INFARCTION; HEART PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; QRS COMPLEX; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET AGGREGATION INHIBITORS; STENTS; VASCULAR PATENCY;

EID: 9644256044     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2004.09.018     Document Type: Article

References (33)

1. L.J. Morrison, P.R. Verbeek, and A.C. McDonald Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis JAMA 283 2000 2686 2692
2. G. Montalescot, P. Barragan, O. Wittenberg for the ADMIRAL Investigators Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction N Engl J Med 344 2001 1895 1903
3. E.J. Topol, F.J. Neumann, and G. Montalescot A preferred reperfusion strategy for acute myocardial infarction J Am Coll Cardiol 42 2003 1886 1889
4. L.F.M. van den Merkhof, F. Zijlstra, and H. Olsson Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (GRAPE) pilot sudy J Am Coll Cardiol 33 1999 1528 1532
5. R. Makkar, B. Goff, and N. Eigler Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI pilot study Catheter Cardiovasc Interv 48 1999 430 434
6. H.R. Arntz, J.F. Schröder, and K. Pels Prehospital versus periprocedural administration of abciximab in STEMI: early and late results from the randomised REOMOBILE-study Eur Heart J 24 2003 268
7. H.M. Gabriel, J. Oliveira, and P.C. da Silva Early administration of abciximab bolus in the emergency room improves microperfusion after primary percutaneous coronary intervention, as assessed by TIMI frame count: results of the ERAMI trial Eur Heart J 24 2003 543
8. S. Zorman, D. Zorman, and M. Noc Effects of abciximab pretreatment in patients with acute myocardial infarction undergoing primary angioplasty Am J Cardiol 90 2002 533 536
9. J.P.S. Henriques, F. Zijlstra, and A.W.J. van't Hof Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade Circulation 107 2003 2115 2119
10. R.H. Selvester, G.S. Wagner, and N.B. Hindman The Selvester QRS scoring system for estimating myocardial infarct size Arch Intern Med 145 1985 1877 1881
11. C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
12. G. Beran, I. Lang, and W. Schreiber Intracoronary thrombectomy with the X-Sizer catheter system improves epicardial flow and accelerates ST-segment resolution in patients with acute coronary syndrome. A prospective, randomized, controlled study Circulation 105 2002 2355 2360
13. G. Destro, P. Marino, and E. Barbieri Postinfarctional remodelling: increased dye intensity in the myocardial risk area after angioplasty of infarct-related coronary artery is associated with reduction of ventricular volumes J Am Coll Cardiol 37 2001 1239 1245
14. M.A. Appleby, A.D. Michaels, M. Chen, and C.G. Michael Importance of the TIMI frame count: implications for future trials Curr Control Trials Cardiovasc Med 1 2000 31 34
15. D. Antoniucci, A. Rodriguez, and A. Hempel A randomized trial comparing primary infarct artery stenting with or without abciximab in acute myocardial infarction J Am Coll Cardiol 42 2003 1879 1885
16. S.J. Brener, L.A. Barr, and J.E.B. Burchenal on behalf of the ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators Circulation 98 1998 734 741
17. F.J. Neumann, R. Blasini, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary artery stents in acute myocardial infarction Circulation 98 1998 2695 2701
18. G.W. Stone, C.L. Grines, D.A. Cox for the Controlled abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction N Engl J Med 346 2002 957 966
19. F.J. Neumann, A. Kastrati, and C. Schmitt Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenenosis rate after the placement of coronary stents following acute myocardial infarction J Am Coll Cardiol 35 2000 915 921
20. H.K. Gold, H.D. Garabedian, and R.E. Dinsmore Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans Circulation 95 1997 1755 1759
21. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group Trial of abciximab with and without low-dose reteplase for acute myocardial infarction Circulation 101 2000 2788 2794
22. J.P. Collet, G. Montalescot, and C. Lesty Effects of abciximab on the architecture of platelet-rich clots in patients with acute myocardial infarction undergoing primary coronary intervention Circulation 103 2001 2328 2331
23. C. Loubeyre, M.C. Morice, and T. Lefevre A randomized comparison of direct stenting with conventrional stent implantation in selected patients with acute myocardial infarction J Am Coll Cardiol 39 2002 15 21
24. R.P. Giugliano, and E. Braunwald Selecting the best reperfusion strategy in ST-elevation myocardial infarction. It's all a matter of time Circulation 108 2003 2828 2830
25. K.A.A. Fox, J. Birkhead, and R. Wilcox British Cardiac Society Working Group on the definition of myocardial infarction Heart 90 2004 603 609
26. G. Montalescot, H.R. Andersen, and D. Antoniucci Summary of recommendations on percutaneous coronary intervention for the reperfusion of acute ST elevation myocardial infarction Heart 90 2004 676 677
27. A.W.J. Van't Hof, N. Ernst, and M.J. de Boer Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME trial) Eur Heart J 25 2004 837 846
28. E.J. Topol, D.J. Moliterno, and H.C. Herrmann Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization N Engl J Med 344 2001 1888 1894
29. E.J. Topol, A.M. Lincoff, and D.J. Kereiakes Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization Am J Med 113 2002 1 6
30. L. Ong, P. Reiser, and J. Coromillas Left ventricular function and rapid release of creatine kinase MB in acute myocardial infarction. Evidence for spontaneous reperfusion N Engl J Med 309 1983 1 6
31. C. Cobbaert, W.T. Hermens, and P.P. Kint Thrombolysis-induced coronary reperfusion causes acute and massive interstitial release of cardiac muscle cell proteins Cardiovasc Res 33 1997 147 155
32. E. Braunwald Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction Circulation 108 2003 III-28 III-37
33. R.J.G. Peters, S.R. Mehta, and K.A.A. Fox Effects of aspirin when used alone or in combination with clopidogrel in patients with acute coronary syndromes. Observations from the Clopidogrel in Unstable angina to prevent Recurrent Evens (CURE) study Circulation 108 2003 1682 1687